GRAF FINCKENSTEIN FRIEDRICH 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
Iovance (IOVA) CMO Graf Finckenstein Receives RSU Award
What Happened
- Graf Finckenstein, Chief Medical Officer of Iovance Biotherapeutics (IOVA), received an award of 58,750 restricted stock units (RSUs) on March 9, 2026. The Form 4 reports the acquisition as a derivative award (code A) with a $0.00 per-share price; no immediate cash value or sale was reported.
Key Details
- Transaction date: 2026-03-09; Form 4 filed: 2026-03-11 (filed timely).
- Security: 58,750 RSUs (each RSU represents a contingent right to one share).
- Reported price: $0.00 (typical for RSU grants); total grant value at issuance not stated on the Form 4.
- Shares owned after transaction: Not specified in the information provided on this filing.
- No 10b5-1 plan, tax-withholding sale, or immediate sale/exercise noted in the filing.
Context
- RSUs are a form of compensation/retention award that convert to actual shares only if and when they vest. Per the filing footnotes, these RSUs vest over three years: one-third on the one-year anniversary, then the remainder in eight equal quarterly installments over the following two years, and only if the reporting person remains employed.
- This is an award (compensation) rather than a market purchase or sale, so it signals company compensation practice rather than an immediate insider buy/sell decision.
Insider Transaction Report
Form 4
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-03-09+58,750→ 58,750 total→ Common stock (58,750 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.
Signature
/s/ Friedrich Graf Finckenstein|2026-03-11